A detailed history of Freestone Capital Holdings, LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 789,719 shares of GRTS stock, worth $23,691. This represents 0.02% of its overall portfolio holdings.

Number of Shares
789,719
Previous 232,658 239.43%
Holding current value
$23,691
Previous $144,000 218.06%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.45 - $0.71 $250,677 - $395,513
557,061 Added 239.43%
789,719 $458,000
Q2 2024

Nov 22, 2024

SELL
$0.62 - $2.35 $345,377 - $1.31 Million
-557,061 Reduced 70.54%
232,658 $144,000
Q2 2024

Aug 13, 2024

BUY
$0.62 - $2.35 $144,247 - $546,746
232,658 New
232,658 $144,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.